Publication | Closed Access

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase

MedicineApoptosisBreast Cancer CellsCell DeathImmune Checkpoint InhibitorBreast CancerAnti-cancer AgentC-jun N-terminal KinaseAntitumor Agent ParthenolidePharmacologyCell BiologyCell SignalingCancer Research